Revolutionizing Cardiac Care: Hospital Santa Maria della Pietà Partners with Stereotaxis for Robotic Ablation Procedures Using Cutting-Edge Technology

Southern Italy’s First Heart Rhythm Patients Treated with Advanced Robotic Technology

On June 11, 2024, Hospital Santa Maria della Pietà in Nola, Southern Italy, established the first robotic cardiac heart program in the region. The hospital has partnered with Stereotaxis (NYSE: STXS) to utilize the cutting-edge Genesis Robotic Magnetic Navigation (RMN) system to successfully treat patients with heart rhythm disorders through robotic ablation procedures.

The adoption of the Genesis system represents a significant advancement in providing top-notch care to patients in Italy. Dr. Mario Volpicelli, Head of the Electrophysiology Unit at the hospital, emphasized the importance of improving patient outcomes with the precision and control offered by the Genesis RMN system. “Robotic Magnetic Navigation brings the benefits of robotic precision and safety to cardiac ablation procedures,” he said. “This technology will revolutionize our ability to treat patients with arrhythmias.”

Giuseppe Russo, General Manager of the hospital, and Luigi Caliendo, Chief of the Cardiology Department, expressed their pride in revolutionizing cardiac treatment through innovative robotic technology. “We are thrilled to be able to offer this cutting-edge technology to our patients,” Russo said. “We believe that it will greatly improve patient outcomes and provide a safer procedure for our patients.”

Stereotaxis Chairman and CEO, David Fischel, highlighted the partnership with Hospital Santa Maria della Pietà in bringing the benefits of robotics to patients in Italy. “This collaboration reflects a shared commitment to advancing standards of care, innovation, and patient-focused solutions in the field of electrophysiology,” Fischel said. “We are excited about this opportunity to work with Hospital Santa Maria della Pietà and help improve patient lives.”

Leave a Reply